Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1998 1
2002 1
2007 1
2008 1
2009 2
2010 1
2011 1
2013 3
2015 3
2016 8
2017 5
2018 1
2019 5
2020 6
2021 5
2022 5
2023 3
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Cremolini C, Antoniotti C, Rossini D, Lonardi S, Loupakis F, Pietrantonio F, Bordonaro R, Latiano TP, Tamburini E, Santini D, Passardi A, Marmorino F, Grande R, Aprile G, Zaniboni A, Murgioni S, Granetto C, Buonadonna A, Moretto R, Corallo S, Cordio S, Antonuzzo L, Tomasello G, Masi G, Ronzoni M, Di Donato S, Carlomagno C, Clavarezza M, Ritorto G, Mambrini A, Roselli M, Cupini S, Mammoliti S, Fenocchio E, Corgna E, Zagonel V, Fontanini G, Ugolini C, Boni L, Falcone A; GONO Foundation Investigators. Cremolini C, et al. Lancet Oncol. 2020 Apr;21(4):497-507. doi: 10.1016/S1470-2045(19)30862-9. Epub 2020 Mar 9. Lancet Oncol. 2020. PMID: 32164906 Free article. Clinical Trial.
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.
Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crinò L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M, Masi G; Gruppo Oncologico Nord Ovest. Falcone A, et al. Among authors: fioretto l. J Clin Oncol. 2007 May 1;25(13):1670-6. doi: 10.1200/JCO.2006.09.0928. J Clin Oncol. 2007. PMID: 17470860 Clinical Trial.
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care).
Zagonel V, Franciosi V, Brunello A, Biasco G, Broglia C, Cattaneo D, Cavanna L, Corsi D, Farina G, Fioretto L, Gamucci T, Lanzetta G, Magarotto R, Maltoni M, Marchetti P, Massa E, Mastromauro C, Melotti B, Meriggi F, Nacci A, Pavese I, Piva E, Quirino M, Roselli M, Sacco C, Tonini G, Trentin L, Ucci G, Labianca R, Gori S, Pinto C, Cascinu S; AIOM Simultaneous and Continuous Care (SCC), Task Force: ESMO Italian DCs. Zagonel V, et al. Among authors: fioretto l. Tumori. 2017 Jan 21;103(1):9-14. doi: 10.5301/tj.5000593. Epub 2016 Dec 19. Tumori. 2017. PMID: 28009422 Free article. Review.
Melanoma diagnosis: traumatic impact of the event on the patient.
Campolmi E, Riccio M, Carli B, Bacci G, Pino MS, Fortunato S, Gunnella S, Fioretto L, Borgognoni L, Pimpinelli N. Campolmi E, et al. Among authors: fioretto l. Ital J Dermatol Venerol. 2021 Jun;156(3):384-387. doi: 10.23736/S2784-8671.19.06348-X. Epub 2019 Jun 12. Ital J Dermatol Venerol. 2021. PMID: 31195781
Body image and awareness in patients with advanced-stage melanoma.
Campolmi E, Mugnai F, Riccio M, Grifoni R, Gunnella S, Fortunato S, Fioretto L, Borgognoni L, Pimpinelli N. Campolmi E, et al. Among authors: fioretto l. G Ital Dermatol Venereol. 2016 Aug;151(4):327-31. Epub 2015 Jan 16. G Ital Dermatol Venereol. 2016. PMID: 25592671
Risk perception, treatment adherence, and personality during COVID-19 pandemic: An international study on cancer patients.
Cheli S, Lam WWT, Estapé T, Winterling J, Bahcivan O, Andritsch E, Weis J, Centeno I, Serpentini S, Farkas C, Wengström Y, Fioretto L, Baider L, Lam CCL, Goldzweig G. Cheli S, et al. Among authors: fioretto l. Psychooncology. 2022 Jan;31(1):46-53. doi: 10.1002/pon.5775. Epub 2021 Aug 4. Psychooncology. 2022. PMID: 34314560 Free PMC article.
48 results